SCHEMBL11070800

SCHEMBL11070800

CCCCCCCCCCCCCCCCNc1ccc(C(=O)NC(=O)C(O)CO)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 3/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MLYCD O95822 1/20 0.44
▸ NAAA Q02083 4/20 0.43
▸ SCN5A Q14524 2/20 0.43
▸ ABCB11 O95342 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ ADRA2B P18089 1/20 0.43
▸ OPRD1 P41143 1/20 0.43
▸ HDAC3 O15379 3/20 0.42
▸ HDAC1 Q13547 3/20 0.42
▸ HDAC2 Q92769 3/20 0.42
▸ LMNA P02545 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ CNR1 P21554 1/20 0.41
▸ DRD4 P21917 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ HRH2 P25021 1/20 0.41
▸ HTR2A P28223 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11545983 0.82 PLK1 (0.45) PLK1L3MBTL1MLYCDSCN5AABCB11
SCHEMBL11074814 0.80 PLK1 (0.53) PLK1L3MBTL1MLYCDNAAASCN5A
SCHEMBL11067061 0.80 L3MBTL1 (0.51) PLK1L3MBTL1MLYCDNAAASCN5A
SCHEMBL11071683 0.78 PLK1 (0.56) PLK1L3MBTL1MLYCDNAAASCN5A
SCHEMBL11065504 0.77 PLK1 (0.51) PLK1L3MBTL1MLYCDNAAASCN5A
SCHEMBL11280317 0.75 PLK1 (0.50) PLK1L3MBTL1SCN5AABCB11CYP3A4
SCHEMBL11277879 0.75 PLK1 (0.50) PLK1L3MBTL1SCN5AABCB11CYP3A4
SCHEMBL10993382 0.75 PLK1 (0.50) PLK1L3MBTL1SCN5AABCB11CYP3A4
SCHEMBL11273393 0.75 PLK1 (0.50) PLK1L3MBTL1SCN5AABCB11CYP3A4
SCHEMBL11287744 0.75 PLK1 (0.50) PLK1L3MBTL1SCN5AABCB11CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4485105-A Method of treating hyperlipidemia with 4-(monoalkylamino)benzoic acid amides AMERICAN CYANAMID COMPANY (US) 1984-11-27 — — US disclosed
US-4242273-A ANTILIPEMIC AND ANTICHOLESTEROL AGENTS AMERICAN CYANAMID COMPANY (US) 1980-12-30 — — US disclosed
US-4136256-A HYPOLIPIDEMIC, ANTIATHEROSCLEROTIC AMERICAN CYANAMID COMPANY (US) 1979-01-23 — — US disclosed
Send feedback